Assessment of the effects of sugammadex on coagulation profiles using thromboelastographic parameters
Not Applicable
Completed
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0002133
- Lead Sponsor
- Konkuk University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients undergoing orthopedic surgery and American Society of Anesthesiology Classification 1 or 2
Exclusion Criteria
1. American Society of Anesthesiology Classification >2
2. Age < 19 yr or > 79 yr
3. Neuromuscular disease patients
4. Allergic history for neuromuscular blocking agents or anesthetic agents
5. Family history of malignant hyperthermia
6. Serum Cr. >= 2 times of normal value or urine output < 0.5ml/kg/hr or Glomerular filtration rate < 60 ml/hr
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method R value of thromboelastographic parameters;K value of thromboelastographic parameters;alpha value of thromboelastographic parameters;MA (maximum amplitude) value of thromboelastographic parameters;LY30 value of thromboelastographic parameters;CI value of thromboelastographic parameters
- Secondary Outcome Measures
Name Time Method Prothombin time;Activated partial thromboplastin time